1
|
Ghazouani L, Khdhiri E, Elmufti A, Zarei A, Feriani A, Baaziz I, Hajji R, Abid M, Ammar H, Abid S, Allouche N, Mnafgui K, Ramazani A, Tlili N. A Novel Synthetized sulfonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulfonohydrazide Protect against Isoproterenol Induced Myocardial Infarction in Rats by attenuating Oxidative damage, Biological Changes, and Electrocardiogram. Clin Exp Pharmacol Physiol 2022; 49:1010-1026. [PMID: 35717592 DOI: 10.1111/1440-1681.13690] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 06/12/2022] [Accepted: 06/14/2022] [Indexed: 11/28/2022]
Abstract
Coumarins and their derivatives are becoming a potential source for new drug discovery due to their vast array of biological activities. The present study was designed to investigate the cardioprotective effects of a newly synthesized coumarin, symbolized as 5,6-PhSHC, against cardiac remodeling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating hematological, biochemical, and cardiac biomarkers. Rats were pre/co-treated with 5,6-PhSHC or clopidogrel (150 μg/kg body weight) daily for a period of 7 days and then MI was induced by injecting ISO (85 mg/kg body weight), at an interval of 24 hours for 2 consecutive days, on 6th and 7th days. The in vivo exploration indicated that the injection of 5,6-PhSHC improved the electrocardiographic (ECG) pattern and prevented severe heart damages by reducing leakage of the cardiac injury markers, such as troponin-T (cTn-T), lactate dehydrogenase (LDH), and creatine kinase-MB. The cellular architecture of cardiac sections, altered in the myocardium of infracted rats, was reversed by 5,6-PhSHC treatment. Results showed that injection of 5,6-PhSHC elicited significant cardioprotective effects by prevention of myocardium cell necrosis and inflammatory cells infiltration, along with marked decrease in plasma levels of fibrinogen. In addition, the total cholesterol, triglyceride, LDL-c, and HDL profiles underwent remarkable beneficial changes. It was also interesting to note that 5,6-PhSHC enhanced the antioxidative defense mechanisms by increasing myocardial glutathione (GSH) level, superoxide dismutase (SOD), and catalase (CAT) activities, together with reducing the levels of thiobarbituric-acid-reactive substances (TBARS), when compared with ISO-induced rats. Taken together, these findings suggested a beneficial role for 5,6-PhSHC against ISO-induced MI in rats. Furthermore, in silico analysis showed that 5,6-PhSHC pocess high computational affinities (E-value > - 9.0 kcal/mol) against cyclooxygenase-2 (PDB-ID: 1CX2), vitamin K epoxide reductase (PDB-ID: 3KP9), glycoprotein IIb/IIIa (PDB-ID: 2VDM) and catalase (PDB-ID: 1DGF). Therefore, the present study provided promising data that the newly synthesized coumarin can be useful in the design and synthesis of novel drug against Myocardial infarction. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Lakhdar Ghazouani
- Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa, Tunisia
| | - Emna Khdhiri
- Laboratoire de Chimie Appliquée "Hétérocycles Corps Gras & Polymères", Faculté des Sciences, Université de Sfax, Sfax, Tunisie
| | - Afoua Elmufti
- Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa, Tunisia
| | - Armin Zarei
- Department of Chemistry, Faculty of Science, University of Zanjan, Zanjan, Iran
| | - Anouar Feriani
- Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa, Tunisia
| | - Intissar Baaziz
- Laboratory of Biotechnology and Biomonitoring of the Environment and Oasis Ecosystems, Faculty of Sciences of Gafsa, University of Gafsa, Gafsa, Tunisia
| | - Raouf Hajji
- Internal Medicine Department, Sidi Bouzid Hospital, Faculty of Medicine of Sousse, University of Sousse, Sousse, Tunisia
| | - Majdi Abid
- Chemistry Department, College of Science and Arts, Jouf University, Jouf, Saudi Arabia
| | - Houcine Ammar
- Laboratoire de Chimie Appliquée "Hétérocycles Corps Gras & Polymères", Faculté des Sciences, Université de Sfax, Sfax, Tunisie
| | - Souhir Abid
- Chemistry Department, College of Science and Arts, Jouf University, Jouf, Saudi Arabia
| | - Noureddine Allouche
- Laboratory of Organic Chemistry LR17ES08 (Natural Substances Team), Faculty of Sciences of Sfax, University of Sfax, Sfax, Tunisia
| | - Kais Mnafgui
- Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax, P.O. Box 95, Sfax, Tunisia
| | - Ali Ramazani
- Department of Chemistry, Faculty of Science, University of Zanjan, Zanjan, Iran
| | - Nizar Tlili
- Higher Institute of Sciences and Technology of Environment of Borj Cedria, University of Carthage, Hammam-Lif, Tunisia
| |
Collapse
|
2
|
Ghazouani L, Khdhiri E, Elmufti A, Feriani A, Tir M, Baaziz I, Hajji R, Ben Mansour H, Ammar H, Abid S, Mnafgui K. Cardioprotective effects of ( E)-4-hydroxy-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide: a newly synthesized coumarin hydrazone against isoproterenol-induced myocardial infarction in a rat model. Can J Physiol Pharmacol 2019; 97:989-998. [PMID: 31464528 DOI: 10.1139/cjpp-2019-0085] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The current study was carried out to evaluate the effect of pretreatment and co-treatment with a newly synthesized coumarin hydrazone, (E)-4-hydroxy-N'-(1-(3-oxo-3H-benzo[f]chromen-2-yl)ethylidene)benzohydrazide (hereinafter EK6), against isoproterenol-induced myocardial infarction in rats. Changes in biochemistry, cardiac biomarkers, electrocardiography, and histopathology after treatment with EK6 or acenocoumarol (Sintrom) were studied. Animals were randomly divided into 4 groups: vehicle control (C), isoproterenol + Sintrom (ISO + Sin), isoproterenol + EK6 (ISO + EK6), and isoproterenol (ISO). Myocardial infarction was induced by subcutaneous ISO administration at a dose of 85 mg·kg-1·day-1 with a drug-free interval of 24 h on days 6 and 7. Treatment with ISO led to significant elevation (p < 0.05) in serum levels of cardiac injury biomarkers, namely cardiac troponin-T, lactate dehydrogenase, creatine kinase-MB, alanine aminotransferase, and aspartate aminotransferase compared with levels in the vehicle control. A change in the lipid profile was also observed as a significant increase in total cholesterol and triglycerides. Furthermore, ISO caused significant alterations in the electrocardiogram pattern, including significant ST-segment elevation, significant decreased R wave amplitude, and significant increase in heart rate (16%) as well as marked changes in the histopathology of the heart tissue. Pretreatment and co-treatment with newly synthesized coumarin hydrazone restored all ISO-induced biochemical, lipid, cardiac, and histopathological changes in rats with myocardial infarction.
Collapse
Affiliation(s)
- Lakhdar Ghazouani
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, 2112 Gafsa, Tunisia
| | - Emna Khdhiri
- Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax, 3038 Sfax, Tunisia
| | - Afoua Elmufti
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, 2112 Gafsa, Tunisia
| | - Anouar Feriani
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, 2112 Gafsa, Tunisia
| | - Meriam Tir
- Research Unit of Physiology and Aquatic Environment, Faculty of Science of Tunis, University Campus, El Manar I, 2092 Tunis, Tunisia
| | - Intissar Baaziz
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, 2112 Gafsa, Tunisia
| | - Raouf Hajji
- Internal Medicine Department, Sidi Bouzid Hospital, Ibn El Jazzar Faculty of Medicine, University of Sousse, Sousse, Tunisia
| | - Hedi Ben Mansour
- Research Unit of Analysis and Processes Applied to the Environment (APAE), Higher Institute of Applied Sciences and Technology of Mahdia, University of Monastir, Monastir, Tunisia
| | - Houcine Ammar
- Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax, 3038 Sfax, Tunisia
| | - Souhir Abid
- Laboratory of Applied Chemistry HCGP, Faculty of Science, University of Sfax, 3038 Sfax, Tunisia.,Chemistry Department, College of Science and Arts, Jouf University, Al Qurayyat, Al Jawf, Saudi Arabia
| | - Kais Mnafgui
- Laboratory of Animal Physiology, Faculty of Sciences of Sfax, University of Sfax, P.O. Box 95, Sfax 3052, Tunisia
| |
Collapse
|
3
|
Ghazouani L, Elmufti A, Baaziz I, Chaabane I, Ben Mansour H. Contribution of adiponectin polymorphisms to the risk of coronary artery disease in a North-African Tunisian population. J Clin Lab Anal 2018; 32:e22446. [PMID: 29633340 DOI: 10.1002/jcla.22446] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2017] [Accepted: 03/08/2018] [Indexed: 01/26/2023] Open
Abstract
BACKGROUND Adiponectin, an adipocyte-derived protein, is known to play a key role in the processes leading to atherosclerosis and coronary artery disease (CAD) through its anti-atherogenic, anti-inflammatory, antioxidative, and anti-apoptotic properties. In the current study, we have studied the association of two single nucleotide polymorphisms (SNPs) +45 T>G (rs2241766) and +276 G>T (rs1501299) of the adiponectin gene with coronary artery disease (CAD) on an Arab/North-African population from Tunisia. METHODS Subjects comprised 277 patients with angiographically demonstrated CAD and 269 age- and gender-matched control subjects. The adiponectin genotypes were performed by polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP). The contribution of adiponectin variants to CAD was analyzed by haplotype and regression analysis. RESULTS Adiponectin +45T>G and +276G>T genotypic and allelic distributions did not show a significant difference between cases and controls. Similarly, no association with CAD was observed for the haplotype analysis. Assuming dominant model of transmission for both polymorphisms and after adjustment of a number of traditional risk factors for CAD, logistic regression analysis showed an association of SNP +45 T>G with increased risk of developing CAD [adjusted OR (95% CI) = 2.59 (1.17-5.70); P = .01]. However, SNP + 276 G>T is associated with decreased risk of developing CAD [adjusted OR (95% CI) = 0.47 (0.22-0.97); P = .04]. CONCLUSION There is no allelic or genotypic association of +45 T>G and +276 G>T of the adiponectin gene with CAD in the Tunisian population.
Collapse
Affiliation(s)
- Lakhdar Ghazouani
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, Gafsa, Tunisia
| | - Afoua Elmufti
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, Gafsa, Tunisia
| | - Intissar Baaziz
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, Gafsa, Tunisia
| | - Ibtissem Chaabane
- Research Unit of Macromolecular Biochemistry and Genetics, Faculty of Sciences of Gafsa, Gafsa, Tunisia
| | - Hedi Ben Mansour
- Research Unit of Analysis and Process Applied to the Environmental-APAE (UR17ES32), Higher Institute of Applied Sciences and Technology Mahdia, University of Monastir, Monastir, Tunisia
| |
Collapse
|